Altair
Skip to content

Trading Analysis Report: BE

Analysis date: 2026-10-14 · Model: claude-opus-5-5 · AI-generated, not financial advice.

  • Analysis date: 2026-10-14
  • Rating: Underweight
  • Generated: 2026-10-14 14:58:45
  • TradingAgents 0.6.0: anthropic, deep claude-opus-5-5, quick claude-sonnet-5-5
  • Analysts: market, sentiment, news, fundamentals; research debate rounds 5, risk debate rounds 5
  • Data vendors: core_stock_apis yfinance, technical_indicators yfinance, fundamental_data sec_edgar,yfinance, news_data yfinance, macro_data fred, prediction_markets polymarket

V. Portfolio Manager Decision

Rating: Underweight

Executive Summary: Reduce BE, but do not exit. Initiate no new long at about 239, open no short, and cut existing holdings to a residual equal to the lesser of one-third of a standard allocation or 1.5% of the book, held through the Q3 print. Sell about half the trim tomorrow in slices across the morning, or three-quarters if BE fell alone versus its peers or the filing read is bad or unfinished. Rest a quarter on limits at 245-249 expiring at the earlier of Oct 20 or the backstop, and sell the remainder at the close on Oct 23 or the last close before the report, whichever comes first. A daily close below 233.93 sends everything unsold to market the next morning, and a daily close below 214.89 halves the residual; the 1-2 month price target is 217.

Current Price: 239.34

Price Target: 217.0

Confidence: Medium

Time Horizon: 1-2 months

IV. Risk Management Team Decision

Aggressive Analyst

Aggressive Analyst: I'll open, since neither of you has spoken yet, and I'll answer your likely objections in advance.

People hear "aggressive" and assume "long." That's lazy. Being aggressive means taking the position with the best payoff and acting before the picture is tidy. Right now that position is a Sell on BE.

The stock is at 239.34 after a 9.15% gap down. It carries a $70.5 billion market cap on about $3.1 billion of trailing revenue, roughly 22.7 times sales, with a beta of 3.78. The 48.6 forward P/E depends on $4.93 of earnings, against 76 cents trailing, which is 6.5 times. Even if you annualize the best quarter on record, 23 cents in Q1, you land under a dollar. The price is paying today for an earnings ramp nobody has shown us. We also don't have the Q2 statements, the Q4 financing terms, or a confirmed earnings date. Refusing to underwrite a number we can't see isn't timid.

Now the payoff math. The stock ran 80.6% from 163.75 to 295.78 in about ten weeks, then gave back 19.1% in six sessions. From here the first overhead zone, the 50 SMA and lower Bollinger band around 249, is only 4% away. The 10 EMA at 268.85 is about 12% away. Downside to the 200 SMA at 214.89 is about 10%, and the weekly SuperTrend stop at 178.81 is 25% below. Roth's new $260 target is only 8.6% above the price. Reclaiming 296 takes nearly 24% and needs a clean beat in a tape that just broke a month-long range. That payoff is a poor trade for a position this size.

To the conservative analyst, who will want to go to zero: I disagree, and I'm the aggressive one here. Revenue grew 134% year over year in Q1, operating income was $72 million, operating cash flow turned positive, and there's $2.49 billion in cash. This stock has produced single-day gaps of +24%, +27.2% and +26.5% this year. Selling everything gives up that right tail for no reason. The weekly and monthly SuperTrends are still up. A residual capped around 2% of the portfolio means a repeat of the 52.7% drawdown costs about 1% of the book, and that is how you keep your upside.

To the neutral analyst, who will say the trend is intact, the Z-score is -2.72, and the stock is oversold: I agree a bounce is likely. ADX is 14.76 and the close is below the lower band. That's why the second half of the trim waits for 245 to 249 instead of dumping at the low. But a bounce is where you sell, not a reason to hold. It runs straight into the 50 SMA and the lower band, 0.21 apart. Meanwhile the MACD histogram has been negative and widening for five sessions at -5.76, RSI fell from 60 to 41, and RSI made lower highs while price made higher highs into the top.

I'd also push back on trusting the 233.93 daily stop. It's 0.27 ATR away, which is noise on a name with ATR near 8%. It's a trigger to finish the trim, not a risk control. For the residual, the review level is a daily close below 214.89.

On sentiment, the 86% bullish tag ratio among labeled StockTwits posts looks reassuring. It comes from 10 unique authors, one of whom accounts for three tags. The 16 unlabeled posts skew frustrated, with "total rout," "added to short list," and "220 is the next stop?" The bullish posts are mostly dip-buying against a falling tape. That's inventory, and if 233.93 goes, those buyers become the supply.

On news, Oracle reaffirmed Project Jupiter, AEP is investing about $4 billion, and Roth raised its target. Yet the stock fell about 19% anyway. The AEP headline doesn't even name Bloom, and the El Paso Electric walk-back and the FERC pipeline dependency show the execution risk is still there. When good news can't hold the price, the news is in the price.

On macro, Polymarket has 97% on no cuts this year and 86% on another hike, with hot inflation and surging global yields. Recession odds are 8% and AI-bubble odds are 6%. A 3.78-beta, long-duration story stock has little fear priced in to cushion a wobble.

Here is where I might be wrong. The Oct 14 bar may not be final. The earnings date is unconfirmed, with retail saying "next week." Friday's monthly expiry could whip the tape either way. The $531 million trailing free cash flow doesn't reconcile with Q1's roughly $48 million, and if it's real and durable, the bull case gets stronger. Insiders sold about $139 million this year and bought nothing, but the quiet since August 17 is probably a blackout, so I won't call it a signal. If earnings gap the stock up, trimming first costs us something. The residual is there to catch part of that.

So the plan stands, and I don't have your portfolio, so apply it to your own book. Make no new long exposure at around 239. Cut existing positions to roughly one-third to one-half of a standard allocation, with the residual capped near 2%. Sell about half the trim now and work the rest toward 245 to 249. Finish the trim immediately on a daily close below 233.93. Treat 214.89 as a full-review level for the residual long, not as a short-side stop. This is a trim, not a short.

FINAL TRANSACTION PROPOSAL: SELL Aggressive Analyst: Before I answer point by point, notice how close we are. All three of us say sell, no new money at 239, keep a small residual. The neutral's plan is mine with a different split: half now, a quarter on limits at 245 to 249 through Friday, the rest before the print, and finish the trim if 233.93 closes. So the neutral's complaint that the 249 limit and the 233.93 trigger are a coin flip hits its own plan equally. My answer is the same either way. With an 8% ATR, both levels are within ordinary reach over a few sessions, and the plan is fine in either order. If 233.93 closes first, the last tranche sells about 5% below the zone I wanted, on a piece I had already decided to sell. That cost is bounded.

That also resolves the "noise or trigger" charge. As a stop on a position I want to keep, a level 0.27 ATR away is useless because it shakes me out of something I wanted. As a pace-setter on a trim I've already decided to make, noise just pulls a sale forward a few days. Those are different jobs.

Conservative, that's also where I part ways on resting orders. Today's low was 235.70, only 1.77 above 233.93, on a day that closed above it. A resting stop there fires on a wick, and a close-based rule filters that out. As the neutral said, a stop-market fills at the open on a gap anyway, so it adds no gap protection. You're right that an 18.5% gap from 239 lands near 195 and skips every level we've named. But if size is the only defense against that, it's an argument for the cap, not for dumping more at the low.

On speed, do the arithmetic. Going from half to two-thirds or three-quarters sells an extra sixth to a quarter of the trim at 239 instead of an expected 247 or so. That costs about 3% on that slice, under 1% of the trim's value. What it buys is protection against a hard gap before Friday that arrives without 233.93 closing first or 245 ever trading. The dataset has one down-gap of that size all year. The technical report also says ADX at 14.76 makes breakdown signals more likely to whipsaw. Selling most of the position into a 2.7-sigma-below-mean day that closed in the bottom sixth of its range is trend-following behavior in a regime where trend-following fails.

You're right that the Z-score is one timeframe, the mean is inflated by the run, RSI at 41 isn't oversold, and the weekly Z is -0.27. I'm not claiming the bounce is certain. I'm saying a deadline protects against the print as well as urgency does, without paying for it at the low. So I'll take the deadline: the close before the report if the date is confirmed, Friday's close if not. It's free, and I should have written it in.

On the right tail, you say a 25% gap from here adds about $17 billion, which is a bigger ask than July's. Fair, but the last six sessions took BE from 295.78 to 239.34, which removed about $16.6 billion of market cap. The market has shown it can move that much either way in a week, so market cap isn't a ceiling. You're right that July started from a depressed 163.75, and I'm not counting on a repeat. That's why the position is a residual, not a bet. The neutral's point that the big up-gaps seem to line up with earnings is the best case for keeping a residual through the print, and I agree with it.

Neutral, you're right that annualizing Q1 is two quarters stale. The TTM revenue of $3.11 billion implies the missing quarters averaged about $930 million. But redo the forward math. TTM gross profit is $985 million. Forward EPS of $4.93 on roughly 300 million shares is about $1.5 billion of net income, more than the entire trailing gross profit. With Q1 operating costs around $154 million a quarter, you'd need roughly $2.1 billion of gross profit. At a 31% gross margin that means about $6.8 billion of revenue, roughly double TTM. That's reachable if growth stays near Q1's 134%, but the price already assumes it holds. A print can confirm that or break it, and a confirming print mostly holds the price.

I'll also concede that "good news couldn't hold the price" overreached. The AEP headline doesn't name BE, the headlines have no timestamps, and the posts group BE with CRWV, NBIS and NVDA. But if this was basket flow, that's the exposure we're trimming. A 3.78-beta name whose price is set by sector flow, not by Oracle headlines, shouldn't be held at full size into a print. I'll also drop StockTwits as anything more than color, and I accept the hike markets are thin. The no-cuts market is the thick one, at about $8.9 million, and the recession and AI-bubble markets, around $2.3 to $2.4 million each, say little fear is priced in.

Conservative, on the balance sheet, I agree cash isn't net cash and a possible convert is worth checking. But that risk exists Friday as well as today, and nothing in the data gives us a strike or a size, so it can't set the pace. The equity gap cuts both ways too. If the snapshot is newer than the statements, the balance sheet may be better than Q1 shows. Nobody gets credit for that until it reconciles.

On sizing, your own criterion, a 60% fall costing under a point of the book, gives a residual of about 1.67%, not 1%. So we're at 1.5% versus 2%, and the neutral is right that the gap is 0.3 points of book at a 60% loss. I'll take the lesser of a third of a standard allocation or 2%, and I won't fight over 1.5%. I won't go to 1%, because the residual only matters if the print gaps 25% in our favor.

So here is the plan I'm defending. Check the earnings date first. Work about half the trim over the next morning. Rest the next piece as limits at 245 to 249 through Friday. Sell the last piece at the close before the report, or Friday's close if the date isn't confirmed. Finish immediately on a daily close below 233.93. Hold the lesser of a third of a standard allocation or 2% of the book. On a daily close below 214.89, halve the residual and re-underwrite the rest. I'll take that from the neutral, because a specific action beats an open-ended review. The aggressive part is being willing to make the market pay for the last piece of the sale.

FINAL TRANSACTION PROPOSAL: SELL Aggressive Analyst: Start with the neutral's pricing, because it settles most of this. Trim a 6% position to 2% and the gap between selling half tomorrow and selling two-thirds is about two-thirds of a point of book. An 8% day on that slice costs five hundredths of a point, and a Jun 26 repeat costs about a tenth. Conservative, you dismissed the 214.89 halving because it saves a tenth, and the extra sixth you want sold at the open is worth the same tenth in the same bad case. Either both matter or neither does.

Now the part of your cost-of-speed argument I think is wrong, not just small. You say waiting only pays if the bounce is several times likelier than a bad day. That sets an 18.5% gap down against a 3% limit fill and leaves out the gap up. A resting sell limit at 245 to 249 fills at the open if BE gaps through it, so the upside isn't capped at 247 in the case you're worried about. With no directional view, the expected price for a slice sold on a limit with a date backstop is about today's close. Waiting costs variance, not expected dollars, and we just priced that variance at five hundredths to a tenth of a point. I'll also drop the 247. I shouldn't have priced the wait there. A daily Z of -2.72 against a weekly -0.27 and ADX at 14.76 doesn't support it, and the plan works if the expected sale is 239.

On "the left tail comes without a catalyst, the right tail needs earnings," the neutral already noted the +24% on Apr 14 came two weeks before the print. This week's tape adds to that. The world affairs report has tech slumping and then rebounding as "AI trade jitters ease," so basket flows reverse on headlines too. With a beta of 3.78, BE inherits that in both directions. A 19% drop with no BE-specific cause is a reason to size small. It isn't evidence that a rebound needs a print.

You also say the trim is sizing to volatility, not a trend signal. I agree, and that's why I want the argument kept in its lane. It justifies the trim and the cap, which all three of us accept. It doesn't tell us whether the last sixth goes in 36 hours or over seven sessions. And you've now said the report is probably late October, which removes the clock that made the rush feel urgent.

Neutral, you're right about my fallback. Friday's close for an unconfirmed date was backwards, because the date is a lookup. I'll take your schedule. Confirm the date and whether it's before the open or after the close. Recompute 233.93, 249 and 214.89 off the final Oct 14 bar. Work half the trim in slices across tomorrow morning, and rest a quarter on limits in 245 to 249 through Tuesday the 20th. Sell the last quarter at the close on Friday the 23rd, or the close before the report if that's earlier, at any price. Unfilled limits join the last piece, and a daily close below 233.93 sends everything unsold to market the next morning, again in slices.

Your worry about two weeks at full volatility is answered by the fixed date. In your example the last quarter is one point of book, and a full 8% day on it is eight hundredths of a point. I'll pay that to avoid selling the bulk into a 2.7-sigma-down close that sat in the bottom sixth of its range.

On the residual, conservative, "a ticket you size to lose" undersells it. It's a regret hedge against being wrong about the trim. The weekly and monthly SuperTrends are up, Q1 revenue grew 134%, and operating cash flow turned positive. TTM revenue of $3.11 billion also implies the two quarters we can't see averaged about $930 million against Q1's $746 million. The stale data we're all arguing from may understate the business. I won't claim the print pays big, though. The neutral is right that I can't say "a confirming print mostly holds the price" and also sell the residual as a 25% lottery ticket. Call it a small bet with a modest expected payout, sized at 1.5% to 2%, whichever you could sit through a gap on. I'll keep the halving at 214.89 for the discipline. It replaces an open-ended review with a specific action, and that matters more than the tenth of a point it saves.

The thing I'd have us all avoid is selling out of BE entirely. This stock has produced +24%, +27.2% and +26.5% gap days this year. If all of this goes in 36 hours and the next gap is up, the book has nothing in it. If we hold a small residual and the next gap is down, we lose a fraction of a point. That is how the aggressive case is made inside a Sell.

I don't know your holdings, so check your actual weight first. If you're at or below target, there's nothing to sell, and if you hold none, there's nothing to buy. Don't short, and don't fund any protection by selling calls.

FINAL TRANSACTION PROPOSAL: SELL Aggressive Analyst: We're close enough now that what's left is tenths of a point of book, so I'll concede what I should and then say what I'd still do differently.

Conservative, you dropped the Thursday and Friday-morning deadline and took the neutral's dates, which was right. I also take your point that waiting costs variance, and that variance scales with the overweight, which none of us can see. I'd been treating one schedule as if it fit every book. It doesn't, and the neutral's rule fixes that. You're also right about 233.93. It was 21% under the Oct 6 close, it said nothing through an 11% grind, and it was never protection. Its only job is to stop us waiting once the tape has made up its mind.

On not rebuilding into the bounce, I agree with the neutral's amendment. Don't buy back because the stock reached 249. But the reason to keep a residual instead of going to zero is that new information can make us bigger again, and the things we say we can't see are mostly lookups. If the Apr 29 and Jul 30 gaps were earnings reactions, as the neutral inferred, then Q2 was reported around July 30 and the filing is public. The Q4 financing will be in the 10-K or an 8-K. Whether the $531 million of free cash flow reconciles, whether the equity gap is new shares or conversions, and whether there's a convert and at what strike are an hour of reading. That's where I'd take risk: sell the size we can't underwrite today, and if the filings reconcile, add back on evidence, even at a higher price. I'd rather pay up with the numbers on the page than hold full size without them.

On the bucket, I side with the neutral. A shared 1.5% cap across BE, CRWV, NBIS and NVDA would tell anyone holding NVDA to own no BE, and then there's no residual and no right tail. I'll take the spirit, though. If your AI-infrastructure exposure is already heavy, run the 1.5% end of the residual. If not, use 2%. The neutral's peer check is the best new idea in this thread. If CRWV, NBIS and NVDA fell with BE today, it's basket flow, and basket flow has reversed on headlines this week, so the schedule is fine as written. If BE fell alone, the unverified Crusoe story gets more weight, and I'd take the faster end of the pace rule. That's a decision rule, not a forecast.

Neutral, you said to pick a number for first-day exposure, so here's mine. I'd accept about one point of book lost on a Jun 26 repeat, which is roughly 5% in BE after tomorrow, not 4%. That only changes the answer for positions between about 6% and 8%, and there by about a tenth of a point. If you hold 10%, we both sell well past half the trim tomorrow. I'm not defending 5% over 4% as a principle. I'm saying pick one before the open and don't renegotiate it at 9:45 when the tape is moving.

You're right that the limit leg gives up the slow right tail while keeping the left, and that's why it's a quarter and not a half. You're also right that "a book with nothing in it" argued with someone who isn't here. I'll say what I actually care about. The residual should be held through the print and not traded away by the pace triggers. It's a regret hedge against being wrong about the trim, sized by what you can sit through, not by the three 24% to 27% gaps repeating. Those gaps show the right tail exists, not that it's coming.

The fundamentals don't change the Sell. A flat Q2 would force Q4 to about $1.1 billion, so the smoother reading is that Q2 grew, but we can't tell. Either way, $4.93 of forward EPS on roughly 294 to 300 million shares is about $1.5 billion of net income. That's more than the entire TTM gross profit of $985 million, so the price still needs revenue to roughly double. The business can be real and improving and the stock can still be a poor holding at full size.

Here is the plan, in order. Before the open, check your actual weight and your AI-infrastructure exposure. Read the Q2 filing and the Q4 financing terms. Look up the report date and whether it's before the open or after the close. Check how CRWV, NBIS and NVDA closed today. Recompute 233.93, 249 and 214.89 off the final Oct 14 bar.

Tomorrow, sell the larger of half the trim or whatever leaves about 5% of the book in BE, in slices across the morning, not at the open. Rest a quarter of the trim on limits in 245 to 249 through Tuesday the 20th. Sell whatever is left at the close on Friday the 23rd, or the close before the report if that comes first, at any price. A daily close below 233.93 sends everything unsold to market the next morning, again in slices.

Hold the lesser of a third of a standard allocation or 2% of the book, 1.5% if your AI bucket is heavy. Keep it through the print, and halve it on a daily close below 214.89. Make no new long at 239, don't short, don't fund protection by selling calls, and don't buy back on price. Re-size on the filings and the print.

So the trader's 248.7 survives only as the top of a limit zone, not as a target. The 214.89 stop becomes a specific halving action. The open-ended pacing becomes a dated schedule. If you're already at or below target, there's nothing to sell, and if you hold none, there's nothing to buy.

FINAL TRANSACTION PROPOSAL: SELL Aggressive Analyst: We've agreed on almost the whole schedule, so I'll only go through the places where the rules still don't hold together. Then I'll give you the plan.

First, the ceiling. The neutral's formula is right: the points of book you'd accept losing on an 18.5% gap, divided by 0.185. That makes the 4 versus 5 argument a disagreement about a personal parameter, not about BE. The conservative also said both of his numbers come from one budget, but they don't quite. 4% times 18.5% is about 0.74 of a point. 1.5% times a 68% fall to this year's low is about 1.03 points. A one-point budget gives 5.4%. I'm fine with either as long as you write the budget down before the open and don't renegotiate it at 9:45.

Second, the heavy-bucket trigger. The neutral threw out the macro pace rule because it would always fire. The heavy test has a milder version of the same flaw. A 20% bucket shock and an 18.5% gap are nearly the same shock, so "heavy" sits at five times the budget and the ceiling sits at 5.4 times. Anyone holding more than five times the budget in BE alone is already heavy before counting a single other name. That's about the same group the ceiling already tells to sell more, so one problem gets two rules and a cliff from half to three-quarters between them. I'd fold it into the formula instead. Subtract what your other AI names would lose in the same bad basket day from the budget, then divide by 0.185. With a one-point budget and a third of a point of exposure elsewhere, the ceiling on BE is about 3.6%. That's continuous and has no extra trigger. It also doesn't tell a plain NVDA holder to own no BE, because you use the move you'd expect from those names, not BE's. I'd keep two discrete faster triggers, BE falling alone and a bad filing read. In that case, pull the last quarter forward into tomorrow's sale so the limit leg stays a quarter.

Third, I'll take back two of my own lines. I said the price needs revenue to roughly double. The neutral is right that this is the top of the range. If the unseen Q2 was near $1.2 billion, the step to my $6.8 billion is about 1.4 times and the stock is nearer 14 times annualized sales. A flat Q2 leaves the doubling intact, and nobody here has read the number. I also said to add back on a clean filing even at a higher price. Selling most of a position and rebuying part of it higher in an 8% ATR name is a whipsaw machine. The print and the guidance are the re-size events. The filing read is a one-way pace input, as the conservative said.

I do push back on his "we're the least-informed holders, so what we can't see is already priced" line. That argument proves too much. If the price holds everything we can't see, it also holds everything that makes us want to trim. The trim isn't an information bet. It's sizing a 3.78 beta at 22.7 times sales, and it stands whether the filing is good or bad. So I'd use the filing read for pace and for nothing else, and not use the market-knows-better line in either direction.

Fourth, macro. The neutral is right that it shouldn't be a pace trigger, because something will always land inside nine sessions. As a date it probably never binds. The hot-inflation headline suggests this month's CPI is already out, which would put the next one about a month away. I'd also expect the October FOMC to fall after the 23rd, but look it up. If I'm right, the date rule costs nothing, and if I'm wrong, the last quarter sells a session early.

On the residual, I'll take the neutral's version: 1.5% by default, and 2% only if your other AI names are light and you'd sit through a gap. That's an eighth of a point on a 25% gap, and I won't spend more words on it. What I'd protect is that the residual rides through the print and isn't sold by any pace trigger. It's the only exposure to the right tail, and the neutral's point that the biggest gaps cluster around earnings is the best reason to hold it.

So the plan is this. Before the open: - Check your actual weight and your other AI exposure. - Write down your loss budget and compute the ceiling. - Look up the report date and whether it's before the open or after the close, plus the CPI and FOMC dates. - See how CRWV, NBIS and NVDA closed today. - Read the Q2 filing and the financing terms. - Recompute 233.93, 249 and 214.89 off the final Oct 14 bar.

Tomorrow, sell half the trim, or whatever gets BE under your ceiling if that's more, in slices across the morning and not at the open. Go to three-quarters if BE fell alone or the filing read is bad. Rest a quarter on limits at 245 to 249 through Tuesday the 20th. Sell whatever is left at the close on Friday the 23rd, or the close before the report or a dated macro event if that comes first, at any price. A daily close below 233.93 sends everything unsold to market the next morning, in slices.

Hold the lesser of a third of a standard allocation or 1.5% of the book, through the print, and halve it on a daily close below 214.89. Make no new long at 239, don't short, don't fund protection by selling calls, and don't buy back on price. If you're already at or below target, there's nothing to sell, and if you hold none, there's nothing to buy.

FINAL TRANSACTION PROPOSAL: SELL